Skip to main content
SpringerLink
Log in

Aclasta: CHMP offers advice over renal impairment

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. European Medicines Agency.Committee for medicinal products for human use (CHMP) 15-19 February 2010. Internet Document: [21 pages], 25 Feb 2010. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aclasta: CHMP offers advice over renal impairment. React. Wkly. 1291, 4 (2010). https://doi.org/10.2165/00128415-201012910-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201012910-00008

Keywords

Search

Navigation